BDKRB1 and gout: In contrast to the joint-protective effects reported in OA model, ACE inhibitors contribute to the onset of gout attacks in a facilitatory manner by lowering the threshold of monosodium urate crystals mass required for the onset of acute gout attacks in a bradykinin B1 receptor-dependent manner [90].